Cardiovascular Research Center, Health Institute, Imam-Ali Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Syst Rev. 2024 May 20;13(1):136. doi: 10.1186/s13643-024-02525-0.
Sexual dysfunction poses a significant challenge for patients with cardiac conditions. Concerning the prevalence of sexual disorders in cardiovascular patients, several seminal studies conducted in various regions of the world have provided diverse facts and figures pertaining to sexual dysfunction among cardiovascular patients. Therefore, the present study aimed to analyze, summarize, and integrate the findings of seminal studies on the effect of underlying factors and estimate the global rate of sexual disorders in cardiovascular patients.
The present systematic review and meta-analysis included studies conducted in 2003-2023. To find the relevant published academic papers, SID, MagIran, PubMed, Scopus, Web of Science (WOS), and Google Scholar databases were searched for keywords using MeSH/Emtree until January 14, 2023. The GRADEpro software was used to evaluate the quality of evidence. The heterogeneity of studies was checked using the I2 index.
An initial number of 2122 studies were found in the first search. Following a precise screening process based on predefined inclusion criteria, a total of 17 studies were deemed suitable for inclusion in the meta-analysis. The global prevalence of sexual disorders in cardiovascular patients was estimated at 62.6% (95% CI: 49.8-73.8%). As the results of the meta-regression showed that as the sample size increased, there was a significant decrease in the overall prevalence of sexual disorders among cardiovascular patients. Additionally, as the study years progressed, both age and JBI score exhibited an upward trend.
The present findings showed a high prevalence of sexual disorders among cardiovascular patients. Therefore, it is recommended that experts and health policymakers enhance their focus on effectively preventing and controlling these disorders. Besides the evidence achieved very low certainty, it is important for the treatment team to prioritize the sexual relations of cardiovascular patients and focus on improving their sexual function. This should be seen as an essential aspect of their overall recovery process.
性功能障碍对患有心脏疾病的患者构成重大挑战。关于心血管病患者性障碍的患病率，世界不同地区的几项开创性研究提供了心血管病患者性功能障碍的各种事实和数据。因此，本研究旨在分析、总结和整合关于潜在因素对性障碍影响的开创性研究结果，并估计心血管病患者性障碍的全球发生率。
本系统评价和荟萃分析纳入了 2003 年至 2023 年期间进行的研究。为了找到相关的已发表学术论文，我们在 SID、MagIran、PubMed、Scopus、Web of Science(WOS)和 Google Scholar 数据库中使用 MeSH/Emtree 搜索关键词，检索截至 2023 年 1 月 14 日。使用 GRADEpro 软件评估证据质量。使用 I2 指数检查研究的异质性。
初次搜索共发现 2122 项研究。经过基于预先设定的纳入标准的精确筛选过程，共有 17 项研究被认为适合纳入荟萃分析。心血管病患者性障碍的全球患病率估计为 62.6%(95%CI：49.8-73.8%)。荟萃回归的结果表明，随着样本量的增加，心血管病患者性障碍的总体患病率显著下降。此外，随着研究年限的推移，年龄和 JBI 评分均呈上升趋势。
本研究结果显示心血管病患者性障碍的患病率较高。因此，建议专家和卫生政策制定者加强关注，有效预防和控制这些障碍。除了证据的确定性非常低之外，治疗团队还应优先考虑心血管病患者的性关系，并专注于改善他们的性功能。这应被视为他们整体康复过程的一个重要方面。
